Current state of knowledge about spironolactone-induded gynecomastia. Review 2024
Spironolactone, a potassium-sparing diuretic, acts as an aldosterone antagonist but also has anti-androgen properties, leading to increased estrogen levels in the body. It can cause gynecomastia in men by blocking the production of androgens, preventing androgens from binding to specific receptors,...
Bewaard in:
Hoofdauteurs: | , , , , , , , , |
---|---|
Formaat: | Boek |
Gepubliceerd in: |
Nicolaus Copernicus University in Toruń,
2024-08-01T00:00:00Z.
|
Onderwerpen: | |
Online toegang: | Connect to this object online. |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|
Internet
Connect to this object online.3rd Floor Main Library
Plaatsingsnummer: |
A1234.567 |
---|---|
Kopie 1 | Beschikbaar |